MALO Clinic China Secures RMB 85 Million Series B Funding and Files for IPO

It is reported that MALO CLINIC China has completed an RMB 85 million Series B financing round, led by GGV Capital (Granite Global Ventures), with participation from Shanghai Liying Investment Management Center, Guangzhou Yili Fuyidaohe Medical Investment Fund, and Hui Capital, the exclusive investor in its Series A round. Hyjoy Capital served as the exclusive financial advisor for this transaction.

Malong DentalWhat kind of company is it?

According to VCBeat, Malo Clinic was founded in Lisbon, Portugal, in 1993 by Dr. Paulo Malo, a globally renowned master in dental implantology and prosthodontics. It was not until 2013 that Malo Clinic officially entered the Chinese market by establishing ZhiLue Malo Investment Management (Shanghai) Co., Ltd.

Maló Clinic is an international professional dental chain that has always adhered to a technology-led approach. Its core competitive advantages lie in a comprehensive global human resources system, strong differentiated technological capabilities, and a unique patient referral network. As one of the world’s premier healthcare groups, Maló Clinic operates across five continents and stands as a global leader in dentistry. With over 19 years of experience in the field, it has set an industry-stunning record: maintaining zero complaints throughout its 19-year history. This achievement underscores Maló Clinic’s position as an industry pacesetter, both in technical expertise and in product and service quality.

In July 2014, after securing nearly $10 million in Series A financing from Grand Hills Capital, Malo Clinic operated 11 clinics and two dental prosthetics processing centers in China.

What makesMa Long ClinicWhy Is It So Favored by Capital?

The core values of Ma Long Clinic primarily encompass two aspects:

1. A Comprehensive Human Resources System:At various clinics of Malo Clinic (China), at least two Portuguese dentists from Malo Clinic’s headquarters are assigned as attending physicians. Additionally, 2–4 local Chinese dentists are selected and sent in batches to the headquarters in Lisbon, Portugal, for 3–6 months of training before returning to work at the domestic clinics. By the end of 2014, 10 foreign dentists were already working at Malo Clinic’s various locations in China, and the headquarters had trained and selected another 6 foreign dentists who were ready to begin working at Chinese clinics at any time. Meanwhile, the headquarters maintained a pool of approximately 30 foreign dentists available to deploy to Malo Clinic (China) or other clinics across Asia for 3–6-month assignments.

2.Robust Technological Differentiation Advantage:Malo Clinic’s competitive advantages lie in its robust technical capabilities and a unique patient referral system. Technically, leveraging Dr. Malo’s MALO CLINIC PROTOCOL for comprehensive full-arch implant solutions—particularly innovations such as the All-on-4® immediate-function implant technique and the patented Malo Clinic Bridge fixed prosthesis—along with seamless collaboration among surgeons, restorative dentists, and dental technicians, enables edentulous patients to achieve same-day reconstruction and immediate loading without bone grafting. This represents a revolutionary innovation in the field of dental implants. Furthermore, the global network’s distinctive patient referral system has equipped Malo Clinic with extensive experience in managing complex and challenging cases.

How do both parties view this round of financing?

Shao Zongzong, Chairman of Malo Clinic China, stated, “China’s dental market offers vast growth potential, but competition is currently highly homogenized. Therefore, Malo Clinic adopts a differentiated competitive strategy, leveraging technological leadership as its core competitive advantage and mode of expansion. Moreover, Malo Clinic is not limited to Beijing, Shanghai, Guangzhou, and Shenzhen; instead, it establishes at least one clinic in every first-tier city. By concentrating its presence in core regions and key cities, the company aims to create an interconnected network.”

GGV Capital, the lead investor in this round, is a leading venture capital firm focused on expansion-stage companies in the United States and Asia. Since its inception, GGV has been dedicated to investing in enterprises with strong management teams, mature product lines or technologies, well-established customer bases, scalable business models, and clear paths to cash flow. Jin Jiong, a partner at GGV, stated, “Maló Group’s globally leading advantages in dental technology and talent development system, combined with the local resources and operational experience of Maló China’s team within the industry, give us confidence that Maló China can become China’s most professional and outstanding dental healthcare service provider, leading the future development of the entire industry.”

Amidst the demographic dividend brought by population aging and the consumption upgrade across society, Malo Clinic, which focuses on the dental niche and pursues a high-end boutique strategy, may have entered its golden era. As an observer and witness to the healthcare industry, VCBeat is pleased to see the emergence of every industry giant and will continue to closely follow the company’s development journey.